Paradoxical activation of Raf by a novel Raf inhibitor

Chemistry and Biology

Volumn 6, Issue 8, 1999, Pages 559-568

  Hall Jackson, Clare A ^a   Eyers, Patrick A ^a   Cohen, Philip ^a   Goedert, Michel ^b   Boyle, F Tom ^c   Hewitt, Neil ^c   Plant, Helen ^c   Hedge, Philip ^c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Anticancer drug; MAP kinase; Protein kinase; Raf; Ras

Indexed keywords

ANIMALIA;

EID: 0033179479     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80088-X     Document Type: Article

References (35)

1. Marshall, C.J. (1995). Specificity of receptor tyrosine kinase signaling - transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
2. Ullrich, A. & Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase-activity. Cell 61, 203-212.
3. Lowenstein, E.J., et al., & Schlessinger, J. (1992). The SH2 and SH3 domain containing protein Grb2 links receptor tyrosine kinases to Ras signaling. Cell 70, 431-442.
4. Pelicci, G., et al., & Pelicci, P.G. (1992). A novel transforming protein (Shc) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70, 93-104.
5. Rozakis-Adcock, M., et al., & Pawson, T. (1992). Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360, 689-692.
6. Li, N., et al., & Schlessinger, J. (1993). Guanine-nucleotide-releasing factor msos1 binds to Grb2 and links receptor tyrosine kinases to Ras signaling. Nature 363, 85-88.
7. Gale, N.W., Kaplan, S., Lowenstein, E.J., Schlessinger, J. & Bar-Sagi, D. (1993). Grb2 mediates the EGF-dependent activation of guanine-nucleotide exchange on Ras. Nature 363, 88-92.
8. Bowtell, D., Fu, P., Simon, M. & Senior, P. (1992). Identification of murine homologs of the drosophila son of sevenless gene - potential activators of Ras. Proc. Natl Acad. Sci. USA 89, 6511-6515.
9. Clarke, S. (1992). Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Ann. Rev. Biochem. 61, 355-386.
10. Traverse, S., Cohen, P., Paterson, H., Marshall, C., Rapp, U. & Grand, J.A. (1993). Specific association of activated MAP kinase kinase kinase (Raf) with the plasma-membranes of Ras-transformed retinal cells. Oncogene 8, 3175-3181.
11. Leevers, S.J., Patterson, H.F. & Marshall, C.J. (1994). Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma-membrane. Nature 369, 411-414.
12. Stokoe, D., Macdonald, S.G., Cadwallader, K., Symons, M. & Hancock, J.F. (1994). Activation of Raf as a result of recruitment to the plasma-membrane. Science 264, 1463-1467.
13. Morrison, D.K. & Cutler, R.E. (1997). The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9, 174-179.
14. Chen, R.H., Sarnecki, C. & Blenis, J. (1992). Nuclear localisation and regulation of Erk encoded and Rsk encoded protein kinases. Mol. Cell. Biol. 12, 915-927.
15. Traverse, S., Gomez, N., Paterson, H., Marshall, C. & Cohen, P. (1992). Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells - comparison of the effects of nerve growth-factor and epidermal growth-factor. Biochem. J. 288, 351-355.
16. Lenormand, P., Sardet, C., Pages, G., L'Allemain, G., Brunet, A. & Pouyssegur, J. (1993). Growth-factors induce nuclear translocation of MAP kinases (p42 MAPK) and (p44 MAPK) but not of their activator MAP kinase kinase (p45 MAPKK) in fibroblasts. J. Cell Biol. 122, 1079-1088.
17. Traverse, S., Seedorf, K., Paterson, H., Marshall, C.J., Cohen, P. & Ullrich, A. (1994). EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4, 694-701.
18. Law, N. & Lydon, N.B. (1996). Emerging Drugs; The Prospect for Improved Medicines. pp 241-261. Ashley Publications Ltd.
19. Bos, J.L. (1989). Ras oncogenes in human cancers - a review. Cancer Res. 49, 4682-4689.
20. Rapp, U.R., et al., & Anderson, W.B. (1988). Raf family serine/threonine protein kinases in mitogen signal transduction. Cold Spring Harbour Symp. Quant. Biol. 53, 173-184.
21. Sivaraman, V.S., Wang, H-Y., Nuovo, G.J. & Malbon, C.C. (1997). Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 99, 1478-1483.
22. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. & Saltiel, A.R. (1995). PD 098059 is a specific inhibitor of the activation of MAP kinase kinase-1 in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
23. Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J. & Saltiel, A.R. (1995). A synthetic inhibitor of the mitogen-activated protein-kinase cascade. Proc. Natl Acad. Sci. USA 92, 7686-7689.
24. Alessi, D.R., Cohen, P., Ashworth, A., Cowley, S., Leevers, S.J. & Marshall, C.J. (1995). Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Methods Enzymol. 255, 279-290.
25. Cross, D.A.E., Alessi, D.R., Vandenheede, J.R., McDowell, H.E., Hundal, H.S. & Cohen, P. (1994). The inhibition of glycogen-synthase kinase-3 by insulin or insulin-like growth factor-1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin - evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J. 303, 21-26.
26. Alessi, D.R. (1997).The protein kinase C inhibitors Ro318220 and GF109203X are equally potent inhibitors of MAPKAP kinase-1b (Rsk-2) and p70 S6 kinase. FEBS Lett. 402,121-123.
27. Hall-Jackson, C.A., Goedert, M., Hedge, P. & Cohen, P. (1999). Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene 18, 2047-2054.
28. Eyers, P.A., Craxton, M., Morrice, N., Cohen, P. & Goedert, M. (1998). Conversion of SB 203580-insensitive MAP kinase family members to drug sensitive forms by a single amino-acid substitution. Chem. Biol. 5, 321-328.
29. Wilson, K.P., et al., & Su, M.S.S. (1997). The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem. Biol. 4, 423-431.
30. Gum, R.J., et al., & Young, P.R. (1998). Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J. Biol. Chem. 273, 15605-15610.
31. Fox, T., et al., & Wilson, K.P. (1998). A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Protein Sci. 7, 2249-2255.
32. Downward, J. (1995). KSR: A novel player in the RAS pathway. Cell 83, 831-834.
33. Tan, Y., Rouse, J., Zhang, A., Cariati, S., Cohen, P. & Comb, M. (1996). FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15, 4629-4642.
34. Burgering, B.M.T., et al., & Bos, J.L. (1991 ). Insulin stimulation of gene-expression mediated by p21 Ras activation. EMBO J. 10, 1103-1109.
35. Hedge P.J. & Boyle F.T. (1998). Use of Phenylamido Derivatives as Raf Kinase Inhibitors - for Treatment of Tumours. Issue date 18/06/98. Int. patent application WO 98/22103.